By Brandon Lowrey ( July 22, 2015, 4:03 PM EDT) -- A California federal judge on Tuesday for a second time refused to certify a proposed class of consumers who claim Eli Lilly & Co. concealed the withdrawal risks associated with its antidepressant Cymbalta, saying the plaintiffs can't show that the alleged misrepresentations caused them to overpay for the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.